These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26454548)

  • 1. Inhibition of cell proliferation and migration by chondroitin sulfate-g-polyethylenimine-mediated miR-34a delivery.
    Liang S; Duan Y; Xing Z; Han H; Zhang A; Li L; Yang Y; Li Q
    Colloids Surf B Biointerfaces; 2015 Dec; 136():577-84. PubMed ID: 26454548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondroitin sulfate-functionalized polyamidoamine as a tumor-targeted carrier for miR-34a delivery.
    Chen W; Liu Y; Liang X; Huang Y; Li Q
    Acta Biomater; 2017 Jul; 57():238-250. PubMed ID: 28511876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically conjugating polyethylenimine with chondroitin sulfate to promote CD44-mediated endocytosis for gene delivery.
    Lo YL; Sung KH; Chiu CC; Wang LF
    Mol Pharm; 2013 Feb; 10(2):664-76. PubMed ID: 23281918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ATP-Responsive Codelivery System of Doxorubicin and MiR-34a To Synergistically Inhibit Cell Proliferation and Migration.
    Wang Y; Chen J; Liang X; Han H; Wang H; Yang Y; Li Q
    Mol Pharm; 2017 Jul; 14(7):2323-2332. PubMed ID: 28591517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoic Acid-Modified Oligoethyleneimine-Mediated miR-34a Delivery to Achieve the Anti-Tumor Efficacy.
    Huang Y; Wang L; Chen Y; Han H; Li Q
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer.
    Xing Z; Gao S; Duan Y; Han H; Li L; Yang Y; Li Q
    Int J Nanomedicine; 2015; 10():5715-27. PubMed ID: 26425080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylboronic acid-functionalized polyamidoamine-mediated miR-34a delivery for the treatment of gastric cancer.
    Song Z; Liang X; Wang Y; Han H; Yang J; Fang X; Li Q
    Biomater Sci; 2019 Mar; 7(4):1632-1642. PubMed ID: 30720809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroitin sulfate-polyethylenimine copolymer-coated superparamagnetic iron oxide nanoparticles as an efficient magneto-gene carrier for microRNA-encoding plasmid DNA delivery.
    Lo YL; Chou HL; Liao ZX; Huang SJ; Ke JH; Liu YS; Chiu CC; Wang LF
    Nanoscale; 2015 May; 7(18):8554-65. PubMed ID: 25897645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Isopropylacrylamide-modified polyethylenimine-mediated miR-29a delivery to inhibit the proliferation and migration of lung cancer cells.
    Xing J; Jia J; Cong X; Liu Z; Li Q
    Colloids Surf B Biointerfaces; 2021 Feb; 198():111463. PubMed ID: 33250420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-Initiating Caveolae-Mediated Endocytosis and GSH-Responsive MiR-34a Gene Delivery System for Enhanced Orthotopic Triple Negative Breast Cancer Therapy.
    Han TY; Huan ML; Cai Z; He W; Zhou SY; Zhang BL
    Adv Healthc Mater; 2023 Dec; 12(32):e2302094. PubMed ID: 37827986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of a new nano-vector with miRNA-135a on malignant glioma.
    Liang C; Sun W; He H; Zhang B; Ling C; Wang B; Huang T; Hou B; Guo Y
    Int J Nanomedicine; 2018; 13():209-220. PubMed ID: 29343959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy.
    Jang E; Kim E; Son HY; Lim EK; Lee H; Choi Y; Park K; Han S; Suh JS; Huh YM; Haam S
    Biomaterials; 2016 Oct; 105():12-24. PubMed ID: 27497057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression.
    Shi S; Han L; Deng L; Zhang Y; Shen H; Gong T; Zhang Z; Sun X
    J Control Release; 2014 Nov; 194():228-37. PubMed ID: 25220161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin Induces Apoptosis by Up-regulating miR-34a in Human Gastric Cancer Cells.
    Wu H; Huang M; Liu Y; Shu Y; Liu P
    Technol Cancer Res Treat; 2015 Dec; 14(6):747-55. PubMed ID: 24988056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.
    Liang G; Zhu Y; Jing A; Wang J; Hu F; Feng W; Xiao Z; Chen B
    Gene Ther; 2016 Dec; 23(12):829-838. PubMed ID: 27482839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A universal gene carrier platform for treatment of human prostatic carcinoma by p53 transfection.
    Han L; Zhao J; Liu J; Duan XL; Li LH; Wei XF; Wei Y; Liang XJ
    Biomaterials; 2014 Mar; 35(9):3110-20. PubMed ID: 24411335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxymethyl Dextran-Stabilized Polyethylenimine-Poly(epsilon-caprolactone) Nanoparticles-Mediated Modulation of MicroRNA-34a Expression via Small-Molecule Modulator for Hepatocellular Carcinoma Therapy.
    Deng X; Yin Z; Zhou Z; Wang Y; Zhang F; Hu Q; Yang Y; Lu J; Wu Y; Sheng W; Zeng Y
    ACS Appl Mater Interfaces; 2016 Jul; 8(27):17068-79. PubMed ID: 27300477
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Shen Y; Liu Y; Gao H; Fei H; Yu W; Hu T; Zheng Y; Bi X; Lin C
    RSC Adv; 2018 Feb; 8(15):8080-8088. PubMed ID: 35542025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.